Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: Clinical and histopathological correlates

Nephrology Dialysis Transplantation

Volumn 25, Issue 11, 2010, Pages 3615-3622

  Keddis, Mira T ^a   Garovic, Vesna D ^a   Bailey, Kent R ^a   Wood, Christina M ^a   Raissian, Yassaman ^a   Grande, Joseph P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Atheroembolic renal disease; Atherosclerotic renal disease; Hypertensive renal disease; Ischaemic nephropathy; Renal artery stenosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DIFFUSE GLOBAL GLOMERULOSCLEROSIS; DISEASE CONTROL; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLOMERULOSCLEROSIS; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY ARTERY EMBOLISM; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY SIZE; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; RISK FACTOR; TUBULOINTERSTITIAL ATROPHY; VASCULAR DISEASE; ARTERIOSCLEROSIS; FIBROSIS; ISCHEMIA; KIDNEY; MIDDLE AGED; PATHOLOGY; VASCULARIZATION;

AGED; ARTERIOSCLEROSIS; FEMALE; FIBROSIS; HUMANS; HYPERTENSION, RENAL; ISCHEMIA; KIDNEY; MALE; MIDDLE AGED; RENAL ARTERY OBSTRUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79952039743     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq269     Document Type: Article

References (19)

1. Lerman L, Textor SC. Pathophysiology of ischemic nephropathy. Urol Clin North Am 2001; 28: 793-803 (Pubitemid 34028042)
2. Textor SC, Wilcox CS. Renal artery stenosis: A common, treatable cause of renal failure? Annu Rev Med 2001; 52: 421-442 (Pubitemid 32195333)
3. Guo H, Kalra PA, Gilbertson DT et al. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation 2007; 115: 50-58 (Pubitemid 46058611)
4. Greco BA, Breyer JA. The natural history of renal artery stenosis: Who should be evaluated for suspected ischemic nephropathy? Semin Nephrol 1996; 16: 2-11 (Pubitemid 26030826)
5. Chade AR, Zhu XY, Grande JP et al. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens 2008; 26: 1651-1660
6. Cheung CM, Patel A, Shaheen N et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron 2007; 107: 35-42
7. Kane GC, Textor SC, Schirger A et al. Revisiting the role of nephrectomy for advanced renovascular disease. Am J Med 2003; 114: 729-735 (Pubitemid 36776354)
8. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984; 11: 383-392 (Pubitemid 14060862)
9. Zierler RE, Bergelin RO, Davidson RC et al. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens 1996; 9: 1055-1061 (Pubitemid 26383487)
10. Caps MT, Perissinotto C, Zierler RE et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98: 2866-2872 (Pubitemid 29003969)
11. Gobe GC, Axelsen RA, Searle JW. Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest 1990; 63: 770-779
12. Truong LD, Farhood A, Tasby J et al. Experimental chronic renal ischemia: Morphologic and immunologic studies. Kidney Int 1992; 41: 1676-1689
13. Smith HW. Unilateral nephrectomy in hypertensive disease. J Urol 1956; 76: 685-701
14. Wright JR, Duggal A, Thomas R et al. Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: Implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant 2001; 16: 765-770 (Pubitemid 32257973)
15. Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med 1997; 214: 27-40
16. Chade AR, Rodriguez-Porcel M, Grande JP et al. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003; 23: 1295-1301 (Pubitemid 36871287)
17. Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207
18. Fried LF. Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease. Kidney Int 2008; 74: 571-576
19. Khong TK, Missouris CG, Belli AM et al. Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. J Hum Hypertens 2001; 15: 431-433 (Pubitemid 32544722)